Form 4: Constellium CTO Granted 5,469 Restricted Stock Units
Insider Transaction Report
Constellium SE's SVP of Manufacturing Excellence and CTO, Ludovic Piquier, was granted 5,469 restricted stock units, vesting in March 2029.
Summary
- Ludovic Piquier, SVP Manufacturing Excellence & CTO of Constellium SE (CSTM), was granted 5,469 ordinary shares in the form of restricted stock units (RSUs).
- The transaction date for this grant was March 12, 2026, with a deemed execution date on the same day.
- The acquisition price for these RSUs was $0, as it represents a grant.
- Following this transaction, Ludovic Piquier beneficially owns 242,713 ordinary shares.
- These restricted stock units will vest in full on March 12, 2029, contingent upon Mr. Piquier's continued employment with Constellium SE.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, primarily for executive retention and alignment, but it is a routine compensation event and not a significant market-moving announcement for the company's overall sentiment.
Positives
- The grant of restricted stock units aligns the executive's long-term interests with those of the shareholders, incentivizing continued performance and retention.
- The increase in beneficial ownership for a key executive demonstrates ongoing commitment to the company's future.
Risks
- The vesting of the 5,469 restricted stock units is subject to Ludovic Piquier's continued employment until March 12, 2029, meaning the shares could be forfeited if employment ceases before this date.
Future Outlook
The grant of restricted stock units with a vesting date in March 2029 indicates a long-term incentive structure for the SVP Manufacturing Excellence & CTO, aligning his future with the company's performance over the next three years.
Industry Context
StockSavvy.ai notes that the grant of restricted stock units is a standard and widely adopted practice for executive compensation across various industries, including the materials and manufacturing sectors where Constellium operates. This method is commonly used to attract, retain, and motivate key executives by linking their compensation directly to the company's long-term stock performance.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of executive compensation is a common practice among publicly traded companies globally, including peers in the aluminum and advanced materials sector.
- The vesting schedule, typically over several years and contingent on continued employment, is standard for such grants, aiming to foster long-term commitment and align executive interests with shareholder value creation.
Stakeholder Impact
- Shareholders: The grant of RSUs aims to align the interests of a key executive with shareholders by tying a portion of his compensation to the company's stock performance over the long term.
- Employees: This compensation structure for a senior executive may serve as a benchmark or incentive for other employees, though it is specific to executive-level compensation.
Next Steps
- The restricted stock units will vest in full on March 12, 2029, subject to Ludovic Piquier's continued employment.
Key Dates
| Date | Description |
|---|---|
| 03/12/2026 | Date of earliest transaction, transaction date, and deemed execution date for the RSU grant. |
| 03/16/2026 | Date the Form 4 was signed by Kristine Carpenter, Attorney-in-Fact for Ludovic Piquier. |
| 03/12/2029 | Full vesting date for the 5,469 restricted stock units, subject to continued employment. |
Recommendation
holdThis Form 4 filing details a routine executive compensation grant and does not contain new fundamental information that would alter the investment thesis for Constellium SE. It is a standard insider transaction, not indicative of a significant change in company outlook or performance.
Keywords
Constellium, CSTM, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.